Max Mikheev

Max Mikheev is the CEO and Chief Science Officer at BIOMEDICAN. Max has also worked as a postdoctoral research fellow at UPMC and the National Institute on Aging, where they conducted research on projects such as self-regulating devices for modulating inflammation and improving cardiac function with mESCs in mouse experimental models of post myocardial infarction chronic heart failure. Max has also worked as a principal investigator at the Research Institute of Clinical And Experimental Lymphology of Siberian Branch of Russian Academy of and as a researcher at the State Research Center of Virology and Biotechnology "Vector."

Max Mikheev has a PhD in Molecular Biology from State Research Center of Virology and Biotechnology "Vector". Max also has an MD in Clinical and Laboratory Diagnostics from Novosibirsk State Medical University (NSMU) and a M.Sc. in Molecular Biology from Novosibirsk State University (NSU).

Some direct reports include Evgeniya Yuzbasheva - Senior Scientist, Dennis O’Neill - President, and Difeng Gao - Lead Scientist.